6 studies found for:    TNFRSF1B
Show Display Options
Rank Status Study
1 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
2 Recruiting A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus
Condition: Localized Squamous Cell Carcinoma of the Esophagus
Interventions: Drug: ND-420;   Procedure: Surgery;   Drug: Cisplatin;   Drug: fluorouracil
3 Completed Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis
Condition: Psoriasis
Interventions: Dietary Supplement: Corn starch;   Dietary Supplement: Unique Marine Algae Concentrate (UMAC);   Dietary Supplement: Golden brown algae
4 Active, not recruiting Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
Conditions: Autoimmune Diseases;   Systemic Inflammatory Process;   Knee Pain Chronic;   Osteoarthritis;   Rheumatoid Arthritis
Interventions: Drug: Fish Oil;   Dietary Supplement: Vitamin D;   Other: placebo pill
5 Unknown  Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype
Conditions: Obstructive Chronic Pulmonary Disease;   Emphysema;   Chronic Bronchitis
Intervention: Other: Combined Training (endurance and strength exercises)
6 Terminated Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Condition: Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years